GDR not running out of Money20 Aug 2024 10:27
Manchester, UK - 30 May 2024: genedrive plc (LSE: GDR), the point of care pharmacogenetic testing company, is pleased to announce that it has conditionally raised total gross proceeds of approximately £2.03 million through the Open Offer and a further circa £1.89 million through the REX Offer both of which were announced on 9 May 2024. Plus contract signed with NHS 91 million and 454 million over 1 and 5 years respectively